EO1001 demonstrates up to ~40-fold greater potency than osimertinib in EGFR ECD-mutant tumor modelsEO4426 (tezacitabine) demonstrates selective targeting of DNA replication machinery and resistance to ...
Chemotherapy can make food taste metallic, bland, or unpleasant, turning everyday eating into a clinical challenge that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results